Literature DB >> 25664102

Cirrhosis-related changes in left ventricular function and correlation with the model for end-stage liver disease score.

Xiaopeng Li1, Shanshan Yu2, Lu Li3, Donggang Han2, Shejiao Dai3, Ya Gao4.   

Abstract

OBJECTIVE: The purpose of our study is to investigate cirrhosis-related left ventricular remodeling and functional changes, further to analyze the correlations with model for end-stage liver disease (MELD) score.
METHODS: A total of 89 cirrhotic patients were enrolled for study and subgrouped according to MELD score: ≤ 9, 10-19, and ≥ 20. Thirty healthy individuals were enrolled as controls. All study participants underwent cardiac assessment of the left ventricle with Doppler echocardiography; the parameters assessed included left ventricular-end systolic diameter (LVESD), left ventricular end-diastolic diameter (LVEDD), interventricular septal thickness (IVST), left ventricular posterior wall thickness (LVPWT), left atrial diameter (LAD), left ventricular ejection fraction (LVEF), cardiac output (CO), mitral flow velocity (VE/VA ratio), and E-wave deceleration time (DT).
RESULTS: The cirrhotic patients had significantly higher LVESD, LVEDD, IVST, LAD, CO and DT than the control group, but significantly lower VE/VA ratio (all P < 0.05). Subgroup analysis showed that the higher the MELD score, the greater the increase in LVESD, LVEDD, IVST, LAD and DT (all P < 0.05). Nearly one-half of the cirrhotic patients showed left atrial enlargement and a VE/VA ratio ≤ 1, and these features were more common in patients with MELD score ≥ 20. LAD, LVEDD and DT were positively correlated with MELD score (r = 0.208, 0.319 and 0.197, respectively; all P < 0.05).
CONCLUSIONS: Patients with cirrhosis had impaired cardiac function, mainly present as left ventricular diastolic dysfunction, and the extent of dysfunction was correlated with the MELD score. Left atrial enlargement and VE/VA ratio ≤ 1 may serve as useful diagnostic indexes for cirrhotic cardiomyopathy.

Entities:  

Keywords:  Liver cirrhosis; cardiac function; cirrhotic cardiomyopathy; echocardiography; left

Year:  2014        PMID: 25664102      PMCID: PMC4307549     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  16 in total

Review 1.  Renal failure in cirrhosis.

Authors:  Pere Ginès; Robert W Schrier
Journal:  N Engl J Med       Date:  2009-09-24       Impact factor: 91.245

2.  Relationship between model for end-stage liver disease score and left ventricular function in patients with end-stage liver disease.

Authors:  Fu-Rong Sun; Ying Wang; Bing-Yuan Wang; Jing Tong; Dai Zhang; Bing Chang
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2011-02

3.  Cardiac and proinflammatory markers predict prognosis in cirrhosis.

Authors:  Signe Wiese; Christian Mortensen; Jens P Gøtze; Erik Christensen; Ove Andersen; Flemming Bendtsen; Søren Møller
Journal:  Liver Int       Date:  2014-01-07       Impact factor: 5.828

4.  Evaluation of cardiac function in patients with liver cirrhosis.

Authors:  Tarek A Abd-El-Aziz; Mohamed Abdou; Ahmed Fathy; Mohamed Wafaie
Journal:  Intern Med       Date:  2010-12-01       Impact factor: 1.271

Review 5.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

6.  Diastolic dysfunction and left atrial volume: a population-based study.

Authors:  Allison M Pritchett; Douglas W Mahoney; Steven J Jacobsen; Richard J Rodeheffer; Barry L Karon; Margaret M Redfield
Journal:  J Am Coll Cardiol       Date:  2005-01-04       Impact factor: 24.094

7.  Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?

Authors:  Edoardo Giannini; Federica Botta; Alessandra Fumagalli; Federica Malfatti; Emanuela Testa; Bruno Chiarbonello; Simone Polegato; Michele Bellotti; Sara Milazzo; Giacomo Borgonovo; Roberto Testa
Journal:  Liver Int       Date:  2004-10       Impact factor: 5.828

8.  Systolic and diastolic dysfunction in cirrhosis: a tissue-Doppler and speckle tracking echocardiography study.

Authors:  Francisco Sampaio; Joana Pimenta; Nuno Bettencourt; Ricardo Fontes-Carvalho; Ana P Silva; João Valente; Paulo Bettencourt; José Fraga; Vasco Gama
Journal:  Liver Int       Date:  2013-04-25       Impact factor: 5.828

9.  Cardiac dysfunction during liver transplantation: incidence and preoperative predictors.

Authors:  Cristina Ripoll; María-Vega Catalina; Raquel Yotti; Luis Olmedilla; José Pérez-Peña; Oreste Lo Iacono; Diego Rincón; Miguel Angel García-Fernández; Javier Bermejo; Rafael Bañares
Journal:  Transplantation       Date:  2008-06-27       Impact factor: 4.939

10.  LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.

Authors:  André Nazar; Mónica Guevara; Marta Sitges; Carlos Terra; Elsa Solà; Carina Guigou; Vicente Arroyo; Pere Ginès
Journal:  J Hepatol       Date:  2012-09-16       Impact factor: 25.083

View more
  5 in total

1.  Living Donor Liver Transplantation in a Cohort of Recipients With Left Ventricular Systolic Dysfunction.

Authors:  Pooja Bhangui; Prashant Bhangui; Manish Aneja; Nishant Sharma; Nikunj Gupta; A S Soin; Vijay Vohra
Journal:  J Clin Exp Hepatol       Date:  2022-03-16

Review 2.  Cardiovascular manifestation of end-stage liver disease and perioperative echocardiography for liver transplantation: anesthesiologist's view.

Authors:  Sangbin Han; Jaesik Park; Sang Hyun Hong; Chul Soo Park; Jongho Choi; Min Suk Chae
Journal:  Anesth Pain Med (Seoul)       Date:  2022-04-22

Review 3.  Cirrhotic cardiomyopathy.

Authors:  Luis Ruiz-del-Árbol; Regina Serradilla
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

4.  Left Ventricular Diastolic Dysfunction is Associated with Renal Dysfunction, Poor Survival and Low Health Related Quality of Life in Cirrhosis.

Authors:  Madhumita Premkumar; Devaraja Devurgowda; Tanmay Vyas; Saggere M Shasthry; Jelen S Khumuckham; Ritu Goyal; Sherin S Thomas; Guresh Kumar
Journal:  J Clin Exp Hepatol       Date:  2018-08-30

5.  Cirrhotic cardiomyopathy: is there any correlation between the stage of cardiac impairment and the severity of liver disease?

Authors:  Rania Hammami; Mouna Boudabbous; Jihen Jdidi; Fatma Trabelsi; Fakher Mroua; Rahma Kallel; Ali Amouri; Dorra Abid; Nabil Tahri; Leila Abid; Samir Kammoun
Journal:  Libyan J Med       Date:  2017-12       Impact factor: 1.657

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.